Home/Filings/4/0001062993-21-004767
4//SEC Filing

KIM DENNIS D 4

Accession 0001062993-21-004767

CIK 0001042074other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 6:57 PM ET

Size

7.4 KB

Accession

0001062993-21-004767

Insider Transaction Report

Form 4
Period: 2021-05-17
KIM DENNIS D
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-05-17+390,000390,000 total
    Exercise: $4.37Exp: 2031-05-16Common Stock (390,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2021-05-17+10,00010,000 total
    Exercise: $4.37Exp: 2031-05-16Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001456750

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:57 PM ET
Size
7.4 KB